<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">Health Сare of the Russian Federation</journal-id><journal-title-group><journal-title xml:lang="en">Health Сare of the Russian Federation</journal-title><trans-title-group xml:lang="ru"><trans-title>Здравоохранение Российской Федерации</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0044-197X</issn><issn publication-format="electronic">2412-0723</issn><publisher><publisher-name xml:lang="en">Federal Scientific Center for Hygiene F.F.Erisman</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">637999</article-id><article-id pub-id-type="doi">10.47470/0044-197X-2022-66-4-313-319</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>PREVENTION OF NONINFECTIOUS DISEASES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ПРОФИЛАКТИКА НЕИНФЕКЦИОННЫХ ЗАБОЛЕВАНИЙ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Compliance of patients with cardiovascular diseases to optimal drug therapy</article-title><trans-title-group xml:lang="ru"><trans-title>Приверженность пациентов с сердечно-сосудистыми заболеваниями оптимальной медикаментозной терапии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Goloshchapov-Aksenov</surname><given-names>Roman S.</given-names></name><name xml:lang="ru"><surname>Голощапов-Аксенов</surname><given-names>Роман Сергеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, DSci., Associate Professor of the Department of cardiology, endovascular and hybrid methods of diagnosis and treatment of the Medical Institute of the Peoples’ Friendship University of Russia, Moscow, 117198, Russian Federation.</p><p>e-mail: mzmo-endovascular@mail.ru </p></bio><bio xml:lang="ru"><p>Доктор мед. наук, доцент каф. кардиологии, рентгенэндоваскулярных и гибридных методов диагностики и лечения ФНМО Медицинского института ФГАОУ ВО «Российский университет дружбы народов», 117198, Москва.</p><p>e-mail: mzmo-endovascular@mail.ru</p></bio><email>mzmo-endovascular@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shaburov</surname><given-names>Raphik I.</given-names></name><name xml:lang="ru"><surname>Шабуров</surname><given-names>Р. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rukodaynyy</surname><given-names>Oleg V.</given-names></name><name xml:lang="ru"><surname>Рукодайный</surname><given-names>О. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Starikov</surname><given-names>Vyacheslav O.</given-names></name><name xml:lang="ru"><surname>Стариков</surname><given-names>В. О.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Peoples’ Friendship University of Russia</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Российский университет дружбы народов»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Central Clinical Hospital “Russian Railways Medicine”</institution></aff><aff><institution xml:lang="ru">ЧУЗ «Центральная клиническая больница "РЖД-Медицина"»</institution></aff></aff-alternatives><content-language>ru</content-language><pub-date date-type="pub" publication-format="electronic" iso-8601-date="2022-09-13"><day>13</day><month>09</month><year>2022</year></pub-date><pub-date date-type="collection"><year>2022</year></pub-date><volume>66</volume><issue>4</issue><fpage>313</fpage><lpage>319</lpage><history><date date-type="received" iso-8601-date="2024-10-25"><day>25</day><month>10</month><year>2024</year></date></history><pub-history><event event-type="received"><event-desc>Received:<date date-type="received" iso-8601-date="2024-10-25"><day>25</day><month>10</month><year>2024</year></date></event-desc></event><event event-type="pub"><event-desc>Published:<pub-date date-type="pub" publication-format="electronic" iso-8601-date="2022-09-13"><day>13</day><month>09</month><year>2022</year></pub-date></event-desc></event></pub-history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Goloshchapov-Aksenov R.S., Shaburov R.I., Rukodaynyy O.V., Starikov V.O.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Голощапов-Аксенов Р.С., Шабуров Р.И., Рукодайный О.В., Стариков В.О.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Goloshchapov-Aksenov R.S., Shaburov R.I., Rukodaynyy O.V., Starikov V.O.</copyright-holder><copyright-holder xml:lang="ru">Голощапов-Аксенов Р.С., Шабуров Р.И., Рукодайный О.В., Стариков В.О.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2023-08-30"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/0044-197X/article/view/637999">https://journals.eco-vector.com/0044-197X/article/view/637999</self-uri><abstract xml:lang="en"><p><bold>Introduction. </bold>An important principle of improving cardiovascular care is to increase the compliance of patients to optimal drug therapy.</p><p><bold>Purpose. </bold>To identify compliance in patients with cardiovascular diseases to optimal drug therapy.</p><p><bold>Materials and methods. </bold>Direct continuous questioning of patients with cardiovascular diseases (<italic>n</italic> = 1,018) was carried out using a modified Morisky D. questionnaire (1986). The survey was carried out by cardiovascular surgeons (<italic>n</italic> = 3) of the Central Clinical Hospital "Russian Railways Medicine". The degree of adherence of patients to the implementation of the recommendations of doctors at the stage of the initial interview and in 6 and 24 months was compared (<italic>p</italic> &lt; 0.05).</p><p><bold>Results. </bold>At the stage of the first consultation low compliance of patients to antihypertensive therapy (23.8%); high compliance to dual antiplatelet therapy was established in patients after endovascular arterials stenting (99%), anticoagulant therapy in patients with atrial fibrillation (86%) and hypoglycemic therapy in patients with diabetes (98%). After follow-up for six months, including the provision of endovascular and surgical care, compliance to optimal drug therapy in patients of all groups increased up to 99.9% (<italic>p</italic> &lt; 0.05). After follow-up for 24 months, the compliance degree to antihypertensive and anticoagulant therapy slightly decreased to 93.8 and 97.5%, respectively (<italic>p</italic> &gt; 0.05).</p><p><bold>Limitations. </bold>To assess compliance to the recommendations of doctors, the results of outpatient follow-up of one thousand eighteen patients with cardiovascular diseases over two years were analyzed, which is a sufficient reference sample.</p><p><bold>Conclusion. </bold>Compared with the initial consultation of patients, their compliance to optimal drug therapy increased during the 12 months of follow-up. Clinical management in the treatment-and-prophylactic process optimizes control over the effectiveness of the implementation of medical prescriptions, including self-control by patients of hemodynamic and other indicators. The formation of trusting relationships in the “doctor-patient” system is the most important principle of the continuity compliance of clinical management of the process of improving public health.</p><p><bold>Compliance with ethical standards. </bold>The conduct of the scientific study was approved by the Ethics Committee of the Medical Institute of the Peoples’ Friendship University of Russia (PFUR), Protocol No. 9 dated June 9, 2022. Before the start of the study, patients gave written informed consent.</p><p><bold>Contribution of the authors:</bold> <italic>Goloshchapov-Aksenov R.S. </italic>—  the concept and design of the study, the analysis and statistical processing of the material, the correction of the text, the formation of tasks and conclusions. <italic>Shaburov R.I. </italic>– the concept and design of the study, the formation of tasks, editing. <italic>Rukodaynyy O.V. </italic>—  the concept and design of the study, the formation of tasks, editing, the formation of conclusions. <italic>Starikov V.O. </italic>—  collection and processing of material, writing a text, compiling a list of references. <italic>All authors </italic>are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.</p><p><bold>Acknowledgment. </bold>The study had no sponsorship.</p><p><bold>Conflict of interest. </bold>The authors declare no conflict of interest.</p><p>Received: March 01, 2021Accepted: March 24, 2021Published: August 30, 2022</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение. </bold>Важным принципом совершенствования сердечно-сосудистой помощи является повышение приверженности пациентов оптимальной медикаментозной терапии.</p><p><bold>Цель. </bold>Выявить приверженность у пациентов сердечно-сосудистыми заболеваниями оптимальной медикаментозной терапии.</p><p><bold>Материал и методы. </bold>Проведено прямое сплошное анкетирование 1018 пациентов с сердечно-сосудистыми заболеваниями. Сравнивали степень приверженности пациентов выполнению рекомендаций врачей на этапе первичного интервью и через 6 и 24 мес.</p><p><bold>Результаты. </bold>На этапе первой консультации выявлена низкая приверженность пациентов гипотензивной терапии (23,8%); высокая приверженность двойной антиагрегантной терапии установлена у пациентов после стентирования артерий (99%), антикоагулянтной терапии — у пациентов с фибрилляцией предсердий (86%), сахароснижающей терапии — у пациентов с сахарным диабетом (98%). Через 6 мес наблюдения, в том числе после оказания рентгенэндоваскулярной и хирургической помощи, приверженность оптимальной медикаментозной терапии у пациентов всех групп увеличилась до 99,9% (<italic>р</italic> &lt; 0,05). Через 24 мес степень приверженности гипотензивной и антикоагулянтной терапии незначительно снизилась до 93,8 и 97,5% соответственно (<italic>p</italic> &gt; 0,05).</p><p><bold>Ограничения исследования: </bold>для оценки приверженности выполнению рекомендаций врачей были проанализированы результаты амбулаторного наблюдения 1018 пациентов с сердечно-сосудистыми заболеваниями за 2 года, что представляет достаточную референтную выборку.</p><p><bold>Заключение. </bold>По сравнению с первичным консультированием приверженность пациентов оптимальной медикаментозной терапии повышалась в течение 12 мес наблюдения. Клинический менеджмент в лечебно-профилактическом процессе оптимизирует контроль эффективности выполнения врачебных назначений, включая самоконтроль пациентами гемодинамических и других показателей. Формирование доверительных отношений в системе «врач–пациент» является наиболее важным принципом непрерывности клинического управления процессом совершенствования медицинской помощи.</p><p><bold>Соблюдение этических стандартов. </bold>Проведение научного исследования одобрено Комитетом по Этике Медицинского института Российского университета дружбы народов (РУДН), протокол № 9 от 09.06.2022. Перед началом исследования пациенты дали письменное информированное добровольное согласие.</p><p><bold>Участие авторов: </bold><italic>Голощапов-Аксенов Р.С. </italic>— концепция и дизайн исследования, сбор, анализ и статистическая обработка материала редакция текста, формирование задач и выводов; <italic>Шабуров Р.И. </italic>— концепция и дизайн исследования, формирование задач, редактирование; <italic>Рукодайный О.В. </italic>— концепция и дизайн исследования, формирование задач, редактирование, формирование выводов; <italic>Стариков В.О. </italic>— сбор и обработка материала, написание текста, составление списка литературы. <italic>Все соавторы </italic>— утверждение окончательного варианта статьи, ответственность за целостность всех частей статьи. </p><p><bold>Финансирование. </bold>Исследование не имело спонсорской поддержки.</p><p><bold>Конфликт интересов. </bold>Авторы декларируют отсутствие явных и потенциальных конфликтов интересов в связи с публикацией данной статьи.</p><p>Поступила 01.03.2021Принята в печать 24.03.2021Опубликована 30.08.2022</p></trans-abstract><kwd-group xml:lang="en"><kwd>cardiovascular diseases</kwd><kwd>adherence</kwd><kwd>optimal medication</kwd><kwd>clinical management</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>сердечно-сосудистые заболевания</kwd><kwd>приверженность</kwd><kwd>оптимальная медикаментозная терапия</kwd><kwd>клинический менеджмент</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Bokeriya L.A., Alekyan B.G. Endovascular Diagnosis and Treatment of Heart and Vascular Diseases in the Russian Federation – 2016 [Endovaskulyarnaya diagnostika i lechenie zabolevaniy serdtsa i sosudov v Rossiyskoy Federatsii – 2016 god]. Moscow; 2017. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Бокерия Л.А., Алекян Б.Г. Эндоваскулярная диагностика и лечение заболеваний сердца и сосудов в Российской Федерации - 2016 год. М.; 2017.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Abramov A.Yu., Goloshchapov-Aksenov R.S., Kicha D.I., Rukodaynyy O.V. Organizational and technological algorithm of primary specialized health care at cardiovascular diseases. Kazanskiy meditsinskiy zhurnal. 2020; 101(3): 394–402. https://doi.org/10.17816/kmj2020-394 (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Абрамов А.Ю., Голощапов-Аксёнов Р.С., Кича Д.И., Рукодайный О.В. Организационно-технологический алгоритм первичной специализированной медико-санитарной помощи при сердечно-сосудистых заболеваниях. Казанский медицинский журнал. 2020; 101(3): 394-402. https://doi.org/10.17816/kmj2020-394</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">WHO. Cardiovascular Diseases (CVDs). Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(CVDs)</mixed-citation><mixed-citation xml:lang="ru">ВОЗ. Сердечно-сосудистые заболевания. Доступно: https://www.who.int/ru/news-room/fact-sheets/detail/cardiovascular-diseases-( CVDs)</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Neumann F.J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U., et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 2019; 40(2): 87–165. Available at: https://doi.org/10.1093/eurheartj/ehy394</mixed-citation><mixed-citation xml:lang="ru">Neumann F.J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U., et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 2019; 40(2): 87-165. Available at: https://doi.org/10.1093/eurheartj/ehy394</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Mozaffarian D., Benjamin E., Go A., Arnett D., Blaha M., Cushman M., et al. Heart disease and stroke statistics-2016 update a report from the American Heart Association. Circulation. 2016; 133(4): e38–360. https://doi.org/10.1161/cir.0000000000000350</mixed-citation><mixed-citation xml:lang="ru">Mozaffarian D., Benjamin E., Go A., Arnett D., Blaha M., Cushman M., et al. Heart disease and stroke statistics-2016 update a report from the American Heart Association. Circulation. 2016; 133(4): e38-360. https://doi.org/10.1161/cir.0000000000000350</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><mixed-citation>World Heart Federation. Cardiovascular Disease Risk Factors. Geneva; 2014.</mixed-citation></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Chowdhury R., Khan H., Heydon E., Shroufi A., Fahimi S., Moore C., et al. Adherence to cardiovascular therapy: A meta-analysis of prevalence and clinical consequences. Eur. Heart J. 2013; 34(38): 2940–8. https://doi.org/10.1093/eurheartj/eht295</mixed-citation><mixed-citation xml:lang="ru">Chowdhury R., Khan H., Heydon E., Shroufi A., Fahimi S., Moore C., et al. Adherence to cardiovascular therapy: A meta-analysis of prevalence and clinical consequences. Eur. Heart J. 2013; 34(38): 2940-8. https://doi.org/10.1093/eurheartj/eht295</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Gu Q., Burt V.L., Dillon C.F., Yoon S. Trends in antihypertensive medication use and blood pressure control among united states adults with hypertension. Circulation. 2012; 126(17): 2105–14. https://doi.org/10.1161/circulationaha.112.096156</mixed-citation><mixed-citation xml:lang="ru">Gu Q., Burt V.L., Dillon C.F., Yoon S. Trends in antihypertensive medication use and blood pressure control among united states adults with hypertension. Circulation. 2012; 126(17): 2105-14. https://doi.org/10.1161/circulationaha.112.096156</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Melzer D., Tavakoly B., Winder R.E., Masoli J.A., Henley W.E., Ble A., et al. Much more medicine for the oldest old: trends in UK electronic clinical records. Age Ageing. 2015; 44(1): 46–53. https://doi.org/10.1093/ageing/afu113</mixed-citation><mixed-citation xml:lang="ru">Melzer D., Tavakoly B., Winder R.E., Masoli J.A., Henley W.E., Ble A., et al. Much more medicine for the oldest old: trends in UK electronic clinical records. Age Ageing. 2015; 44(1): 46-53. https://doi.org/10.1093/ageing/afu113</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Santra G. Assessment of adherence to cardiovascular medicines in rural population: an observational study in patients attending a tertiary care hospital. Indian J. Pharmacol. 2015; 47(6): 600–4. https://doi.org/10.4103/0253-7613.169573</mixed-citation><mixed-citation xml:lang="ru">Santra G. Assessment of adherence to cardiovascular medicines in rural population: an observational study in patients attending a tertiary care hospital. Indian J. Pharmacol. 2015; 47(6): 600-4. https://doi.org/10.4103/0253-7613.169573</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Weinberger M., Oddone E.Z., Henderson W.G. Does increased access to primary care reduce hospital readmissions? Veterans affairs cooperative study group on primary care and hospital readmission. N. Engl. J. Med. 1996; 334(22): 1441–7. https://doi.org/10.1056/nejm199605303342206</mixed-citation><mixed-citation xml:lang="ru">Weinberger M., Oddone E.Z., Henderson W.G. Does increased access to primary care reduce hospital readmissions? Veterans affairs cooperative study group on primary care and hospital readmission. N. Engl. J. Med. 1996; 334(22): 1441-7. https://doi.org/10.1056/nejm199605303342206</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Leslie K.H., McCowan C., Pell J.P. Adherence to cardiovascular medication: a review of systematic reviews. J. Public Health (Oxf.). 2019; 41(1): e84–94. https://doi.org/10.1093/pubmed/fdy088</mixed-citation><mixed-citation xml:lang="ru">Leslie K.H., McCowan C., Pell J.P. Adherence to cardiovascular medication: a review of systematic reviews. J. Public Health (Oxf.). 2019; 41(1): e84-94. https://doi.org/10.1093/pubmed/fdy088</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24(1): 67–74. https://doi.org/10.1097/00005650-198601000-00007</mixed-citation><mixed-citation xml:lang="ru">Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24(1): 67-74. https://doi.org/10.1097/00005650-198601000-00007</mixed-citation></citation-alternatives></ref></ref-list></back></article>
